PAN-Biotech · PAN-Celltech · Knowledge Hub
Case studies
Real proof from PAN's GMP downstream and supply partnerships – each customer anonymised, each story on its own page.
CS-01Vaccine
~50,000 L of GMP supply in under five weeks
Quote in 3 days; ~50,000 L delivered in under five weeks from first production, to GMP.
CS-02OEM
A two-year OEM bridge, delivered under pressure
A regulatory shutdown took a global supplier's US site offline. PAN bridged ~25 products – ~300,000 bottles over ~2 years, no rejections recorded.
CS-03CMO / CDMO
A private-label GMP line for Europe
A global brand launched a private-label GMP (EU Annex 1) line in Europe – without building a plant.
CS-04Supply
Securing supply after a supplier discontinuation
An incumbent supplier exited; PAN took the RUO product end-to-end under PAN Complete.
CS-05mAb
From in-house buffer prep to a qualified GMP supply partner
A monoclonal-antibody developer moves from making its own buffers to one audited GMP source.
CS-06Cell therapy
WFI Beyond in 1 mL vials for clinical CAR-T manufacturing
A CAR-T developer needed nuclease-free, ultra-low-endotoxin water for plasmid dilution. PAN custom-filled WFI Beyond into 1 mL vials – enquiry to release in ~8 weeks.
CS-07Cell therapy Scaling up WFI for a GMP clean room A cell and gene therapy manufacturer scaled up its WFI demand - WFI Beyond in single-use bags up to 1000 L stays outside the clean room; only the line enters, aseptically, through a wall connector.